Trials / Unknown
UnknownNCT02231736
Chromosomal Damage in Type 2 Diabetes Patients (MIKRODIAB)
Incidence of Chromosomal Damage in Type 2 Diabetes Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 130 (estimated)
- Sponsor
- University of Vienna · Academic / Other
- Sex
- Female
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine whether glycemic control (HbA1c) is linked to chromosomal damage in type 2 Diabetes patients
Conditions
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2015-02-01
- First posted
- 2014-09-04
- Last updated
- 2014-09-04
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT02231736. Inclusion in this directory is not an endorsement.